SCHEMBL18950499

SCHEMBL18950499

CCCCCCC(C)(CC)c1c[nH]c(O)n1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 5/20 0.31
▸ CNR1 P21554 4/20 0.31
▸ CNR2 P34972 3/20 0.31
▸ ALPL P05186 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18610303 0.94 CNR1 (0.33) GPR84CNR1CNR2
SCHEMBL18411002 0.92 CNR1 (0.32) GPR84CNR1CNR2
SCHEMBL19573801 0.84 CNR1 (0.38) CNR1CNR2
SCHEMBL19618192 0.83 CNR2 (0.31) CNR2
SCHEMBL18431659 0.78 — —
SCHEMBL22420048 0.78 — —
SCHEMBL18431565 0.78 — —
SCHEMBL22420133 0.78 — —
SCHEMBL21718623 0.76 CNR2 (0.33) CNR1CNR2
SCHEMBL25913941 0.76 KCNH2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676742-B2 Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-06-13 — — US disclosed
Send feedback